{"id":67,"date":"2018-08-06T04:06:53","date_gmt":"2018-08-06T04:06:53","guid":{"rendered":"https:\/\/www.ladrxcorp.com\/?page_id=67"},"modified":"2022-09-26T16:17:33","modified_gmt":"2022-09-26T16:17:33","slug":"aldoxorubicin","status":"publish","type":"page","link":"https:\/\/www.ladrxcorp.com\/aldoxorubicin\/","title":{"rendered":"Aldoxorubicin"},"content":{"rendered":"<div id=\"cs-content\" class=\"cs-content\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Aldoxorubicin &#8211; A New Approach to Cancer TreatmentAldoxorubicin is a rationally-engineered cytotoxic which delivers well-established anti-cancer agent, doxorubicin, into the tumor. Currently in late-stage clinical trials, aldoxorubicin appears to overcome the key limitations of doxorubicin, &#8230; <a href=\"https:\/\/www.ladrxcorp.com\/aldoxorubicin\/\" class=\"more-link\">Read More<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-layout-sidebar-content.php","meta":[],"_links":{"self":[{"href":"https:\/\/www.ladrxcorp.com\/wp-json\/wp\/v2\/pages\/67"}],"collection":[{"href":"https:\/\/www.ladrxcorp.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ladrxcorp.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ladrxcorp.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ladrxcorp.com\/wp-json\/wp\/v2\/comments?post=67"}],"version-history":[{"count":6,"href":"https:\/\/www.ladrxcorp.com\/wp-json\/wp\/v2\/pages\/67\/revisions"}],"predecessor-version":[{"id":1519,"href":"https:\/\/www.ladrxcorp.com\/wp-json\/wp\/v2\/pages\/67\/revisions\/1519"}],"wp:attachment":[{"href":"https:\/\/www.ladrxcorp.com\/wp-json\/wp\/v2\/media?parent=67"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}